next steps for the trimm-2 study of combination therapies for multiple myeloma
Published 2 years ago • 269 plays • Length 1:21Download video MP4
Download video MP3
Similar videos
-
4:30
next steps for myeloma research and treatment
-
2:28:59
new strategies for multiple myeloma care: next steps for the future
-
2:47
talquetamab daratumumab is well tolerated in relapsed/refractory multiple myeloma patients
-
8:26
triple combination therapies for multiple myeloma (mm) patients
-
5:07
a new horizon: melflufen for r/r multiple myeloma
-
0:59
rationale for combination therapy in multiple myeloma
-
2:40:39
new strategies for multiple myeloma care: next steps to the future
-
2:16
the utility of next-generation sequencing for multiple myeloma
-
40:06
multiple myeloma: a pathway to better outcomes
-
18:11
treatment & management of newly diagnosed multiple myeloma
-
2:22
recent drug approvals for the treatment of relapsed/refractory multiple myeloma
-
12:02
participating in a multiple myeloma clinical trial part 1: your questions answered
-
6:12
ash 2018: using daratumumab early with standard myeloma combos for newly diagnosed patients
-
59:53
clinical trials in multiple myeloma
-
5:31
mayo clinic researchers identify successful combination therapies to treat myeloma patients
-
3:57
bringing dara into the first-line for multiple myeloma
-
3:36
advances in monoclonal antibody therapy for multiple myeloma
-
1:22
future treatment options for multiple myeloma
-
3:41
toxicity considerations for multiple myeloma combination therapies